Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease
- 8 June 1999
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (22) , 2858-2860
- https://doi.org/10.1161/01.cir.99.22.2858
Abstract
Background—Remnant lipoproteins are atherogenic, but assays of remnants have not been available in routine clinical laboratories because of the lack of practical and validated methods. A simple and...Keywords
This publication has 5 references indexed in Scilit:
- Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin.Circulation, 1994
- Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.Circulation, 1993
- Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gelsClinica Chimica Acta; International Journal of Clinical Chemistry, 1993
- Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100.Journal of Lipid Research, 1992
- Transport of beta-very low density lipoproteins and chylomicron remnants by macrophages is mediated by the low density lipoprotein receptor pathway.Journal of Biological Chemistry, 1987